Cargando…

Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Zhao, Yu, Zhao, Zixian, Wang, Yujia, Zhou, Yueqing, Ma, Yu, Zuo, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462411/ https://www.ncbi.nlm.nih.gov/pubmed/32663409 http://dx.doi.org/10.1164/rccm.202001-0179LE

Ejemplares similares

Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2
por: Cai, Guoshuai, et al.
Publicado: (2020)

ACE2 expression is regulated by AhR in SARS-CoV-2-infected macaques
por: Lv, Jiadi, et al.
Publicado: (2021)

Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells
por: Ma, Huabin, et al.
Publicado: (2021)

Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
por: Cao, Yanan, et al.
Publicado: (2020)

Cryo-EM structures of SARS-CoV-2 BA.2-derived subvariants spike in complex with ACE2 receptor
por: Li, Yaning, et al.
Publicado: (2023)

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2
por: Shen, Yaping, et al.
Publicado: (2022)

Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein–ACE2 interaction
por: Yuan, MengYa, et al.
Publicado: (2021)

Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication
por: Pang, Xiaocong, et al.
Publicado: (2020)

Combustible and Electronic Cigarette Exposures Increase ACE2 Activity and SARS-CoV-2 Spike Binding
por: Ghosh, Arunava, et al.
Publicado: (2021)

Erratum: Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2
Publicado: (2021)

Reissuing the sigma receptors for SARS-CoV-2
por: Yesilkaya, Umit Haluk, et al.
Publicado: (2020)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium
por: Pouwels, Simon D., et al.
Publicado: (2023)

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
por: Arora, Prerna, et al.
Publicado: (2022)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Potential implications of SARS-CoV-2 on pregnancy
por: Tseng, Jen-Yu
Publicado: (2020)

Expression of ACE2—a Key SARS-CoV-2 Entry Factor—Is Not Increased in the Nasal Mucosa of People with Cystic Fibrosis
por: Sala, Marc A., et al.
Publicado: (2022)

Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction
por: Zheng, Yun-zhe, et al.
Publicado: (2023)

SARS-CoV-2 infection in conjunctival tissue
por: Liu, Yu-Chi, et al.
Publicado: (2020)

Oral cancer and ACE2 receptor of SARS-CoV-2
por: Martelli-Júnior, Hercílio, et al.
Publicado: (2020)

The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Gong, Yanqiu, et al.
Publicado: (2021)

ACE2-Independent Alternative Receptors for SARS-CoV-2
por: Lim, Suhyeon, et al.
Publicado: (2022)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
por: Ge, Jiwan, et al.
Publicado: (2021)

Single-cell transcriptome profiling of the vaginal epithelium reveals the heterogeneity of suprabasal cells
por: Liang, Chen, et al.
Publicado: (2023)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

SARS-CoV2 Endotheliopathy: Insights from Single Cell RNAseq
por: Khatun, Mst Shamima, et al.
Publicado: (2022)

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity
por: Ramanathan, Muthukumar, et al.
Publicado: (2021)

hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants
por: Liu, Junli, et al.
Publicado: (2021)

Imatinib is not a potent anti-SARS-CoV-2 drug
por: Zhao, Helong, et al.
Publicado: (2020)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

The proximal origin of SARS-CoV-2
por: Andersen, Kristian G., et al.
Publicado: (2020)

SARS-CoV-2 Infection in Children
por: Lu, Xiaoxia, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain
por: George, Thukalan Paulose
Publicado: (2020)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in Spain
por: Hoffmann, Christian, et al.
Publicado: (2020)

SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability
por: Foster, Charles S.P., et al.
Publicado: (2022)

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
por: Rössler, Annika, et al.
Publicado: (2022)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ut16jg3nabfrjn44mo6ck59p4a